CBD as a food ingredient has essentially been on hold since European authorities declared cannabinoids to be “novel” – meaning they have not been consumed in the EU for long enough for safety to be guaranteed. The European Commission has also begun to wonder if they were a food item at all or if they would better fit under the definition of a narcotic as laid out in international treaties.

CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.

As well as the wide-ranging discussion of issues, he also discusses how – despite the current situation  – it might be an opportunity for the European sector and the market as a whole.

To further understand the impact and get the necessary background on Novel Food regulations and the industry, CBD-Intel recommends reading our exclusive report, which can be found here.

If you need further details, feel free to contact us through this form or through any of our regular channels.

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization